AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $124.95 million. The enterprise value is $158.81 million.
| Market Cap | 124.95M |
| Enterprise Value | 158.81M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 30.78 million shares outstanding. The number of shares has increased by 11.12% in one year.
| Current Share Class | 30.78M |
| Shares Outstanding | 30.78M |
| Shares Change (YoY) | +11.12% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 19.00% |
| Float | 30.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.73 |
| Forward PS | 1.42 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.47
| Current Ratio | 0.47 |
| Quick Ratio | 0.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -40.78% |
| Return on Invested Capital (ROIC) | -76.62% |
| Return on Capital Employed (ROCE) | 261.19% |
| Weighted Average Cost of Capital (WACC) | 13.96% |
| Revenue Per Employee | $320,119 |
| Profits Per Employee | -$200,615 |
| Employee Count | 226 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 1.86 |
Taxes
| Income Tax | -8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.89% in the last 52 weeks. The beta is 1.86, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.86 |
| 52-Week Price Change | -27.89% |
| 50-Day Moving Average | 4.27 |
| 200-Day Moving Average | 4.22 |
| Relative Strength Index (RSI) | 44.03 |
| Average Volume (20 Days) | 370,337 |
Short Selling Information
The latest short interest is 3.22 million, so 10.58% of the outstanding shares have been sold short.
| Short Interest | 3.22M |
| Short Previous Month | 3.30M |
| Short % of Shares Out | 10.58% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.62 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $72.35 million and -$45.34 million in losses. Loss per share was -$1.57.
| Revenue | 72.35M |
| Gross Profit | 58.86M |
| Operating Income | -39.51M |
| Pretax Income | -45.35M |
| Net Income | -45.34M |
| EBITDA | -37.11M |
| EBIT | -39.51M |
| Loss Per Share | -$1.57 |
Balance Sheet
The company has $14.26 million in cash and $48.12 million in debt, with a net cash position of -$33.86 million or -$1.10 per share.
| Cash & Cash Equivalents | 14.26M |
| Total Debt | 48.12M |
| Net Cash | -33.86M |
| Net Cash Per Share | -$1.10 |
| Equity (Book Value) | -23.17M |
| Book Value Per Share | -0.75 |
| Working Capital | -35.02M |
Cash Flow
In the last 12 months, operating cash flow was -$30.96 million and capital expenditures -$803,000, giving a free cash flow of -$31.76 million.
| Operating Cash Flow | -30.96M |
| Capital Expenditures | -803,000 |
| Depreciation & Amortization | 2.40M |
| Net Borrowing | 6.10M |
| Free Cash Flow | -31.76M |
| FCF Per Share | -$1.03 |
Margins
Gross margin is 81.36%, with operating and profit margins of -54.61% and -62.67%.
| Gross Margin | 81.36% |
| Operating Margin | -54.61% |
| Pretax Margin | -62.68% |
| Profit Margin | -62.67% |
| EBITDA Margin | -51.29% |
| EBIT Margin | -54.61% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.12% |
| Shareholder Yield | -11.12% |
| Earnings Yield | -36.28% |
| FCF Yield | -25.42% |
Analyst Forecast
The average price target for AVITA Medical is $9.01, which is 121.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.01 |
| Price Target Difference | 121.92% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 21.59% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
AVITA Medical has an Altman Z-Score of -12.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.14 |
| Piotroski F-Score | 2 |